title: Upping the bid on engineered inducible cell death.
authors.affiliation: Department of Microbiology & Immunology, Leo Jenkins Cancer Center, Brody School of Medicine at East Carolina University, Greenville, NC 27858, USA. mccubreyj@mail.ecu.edu
authors.forename: James A
authors.initials: JA
authors.lastname: McCubrey
authors.forename: Fred E
authors.initials: FE
authors.lastname: Bertrand
mesh_terms: D017209:Apoptosis / Q000187:drug effects*; D051023:BH3 Interacting Domain Death Agonist Protein / Q000378:metabolism*; D045744:Cell Line, Tumor; D004318:Doxycycline / Q000494:pharmacology*; D005818:Genetic Engineering / Q000379:methods*; D005822:Genetic Vectors; D049452:Green Fluorescent Proteins / Q000378:metabolism; D006801:Humans; D014162:Transfection; D019076:Transgenes
chemical_list: D051023:BH3 Interacting Domain Death Agonist Protein; D049452:Green Fluorescent Proteins; D004318:Doxycycline